• Adamsen S, Olsen M, Jendresen MB, Holck S, Glenthoj A 2006 Endobiliary brush biopsy: intra- and interobserver variation in cytological evaluation of brushings from bile duct strictures. Scand. J. Gastroenterol. 41: 597-603. *

• Barnes DS 2002 Intrahepatic cholestatic liver disease. http://www.clevelandclinicmeded.com/diseasemanagement/gastro/intrahepatic/intrahepatic1.htm.

• Baron TH, Fleischer DE 2002 Past, present, and future of endoscopic retrograde cholangiopancreatography: perspectives on the National Institutes of Health consensus conference. Mayo Clin. Proc. 77: 407-412. *

• Bergquist A 2003 Tumor markers and genetic markers in the diagnosis of bile duct carcinoma. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 91. October 15-16. *

• Bernstein CL, Stiffler HL, Jowell PS, Branch MS, Baillie J 2003 Classifying low-grade dysplasia (LGD) as "negative" for malignancy increases the specificity but not the sensitivity of biliary brush cytology in primary sclerosing cholangitis (PSC). Gastrointest. Endosc. 57: AB198.

• Bjoro K, Brandsaeter B, Foss A, Schrumpf E 2006 Liver transplantation in primary sclerosing cholangitis. Semin. Liver Dis. 26: 69-79. *

• Boberg KM, Jebsen P, Clausen OP, Aabakken L, Brekke I, Schrumpf E 2003 Cholangiocarcinoma in situ in primary sclerosing cholangitis: diagnosis by brush cytology and treatment by liver transplantation. J. Hepatol. 39: 453. *

• Boberg KM, Jebsen P, Clausen OP, Foss A, Aabakken L, Schrumpf E 2006 Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis. J. Hepatol. 45: 568-574. *

• Boberg KM, Schrumpf E 2004 Diagnosis and treatment of cholangiocarcinoma. Curr. Gastroenterol. Rep. 6: 52-59.

• Brugge WR 2005 Endoscopic techniques to diagnose and manage biliary tumors. J. Clin. Oncol. 23: 4561-4565.

• Chapman RW 2003 The management of primary sclerosing cholangitis. Curr. Gastroenterol. Rep. 5: 9-17.

• Dewitt J, Misra VL, Leblanc JK, McHenry L, Sherman S 2006 EUS-guided FNA of proximal biliary strictures after negative ERCP brush cytology results. Gastrointest. Endosc. 64: 325-333.

• Fevery J, Verslype C, Lai G, Aerts R, Van Steenbergen W 2007 Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis. Dig. Dis. Sci. 52: 3123-3135. *

• Fleming KA 2003 Histology and brush cytology for diagnosis of bile duct carcinoma in primary sclerosing cholangitis. Falk Symposium 136. XII FALK LIVER WEEK 2003 (Part I) In Honour of Hans Popper’s 100th Birthday. Cholestatic Liver Diseases: Therapeutical Options and Perspectives. Freiburg (Germany). p. 92. October 15-16. *

• Fritscher-Ravens A, Broering DC, Knoefel WT, Rogiers X, Swain P, Thonke F, Bobrowski C, Topalidis T, Soehendra N 2004 EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinoma in potentially operable patients with negative brush cytology. Am. J. Gastroenterol. 99: 45-51. *

• Furmanczyk PS, Grieco VS, Agoff SN 2005 Biliary brush cytology and the detection of cholangiocarcinoma in primary sclerosing cholangitis: evaluation of specific cytomorphologic features and CA19-9 levels. Am. J. Clin. Pathol. 124: 355-360.

• Glasbrenner B, Ardan M, Boeck W, Preclik G, Moller P, Adler G 1999 Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography. Endoscopy 31: 712-717.

• Gores GJ 2000 Early detection and treatment of cholangiocarcinoma. Liver Transpl. 6: S30-S34. *

• Gress TM 2004 Molecular diagnosis of pancreatobiliary malignancies in brush cytologies of biliary strictures. Gut 53: 1727-1729. *

• Harewood GC, Baron TH, Stadheim LM, Kipp BR, Sebo TJ, Salomao DR 2004 Prospective, blinded assessment of factors influencing the accuracy of biliary cytology interpretation. Am. J. Gastroenterol. 99: 1464-1469. *

• Henke AC, Jensen CS, Cohen MB 2002 Cytologic diagnosis of adenocarcinoma in biliary and pancreatic duct brushings. Adv. Anat. Pathol. 9: 301-308.

• Huang C, Lichtenstein DR 2002 Pancreatic and biliary tract disorders in inflammatory bowel disease. Gastrointest. Endosc. Clin. N. Am. 12: 535-559.

• Khalid A, Pal R, Sasatomi E, Swalsky P, Slivka A, Whitcomb D, Finkelstein S 2004 Use of microsatellite marker loss of heterozygosity in accurate diagnosis of pancreaticobiliary malignancy from brush cytology samples. Gut 53: 1860-1865. *

• Kipp BR, Stadheim LM, Halling SA, Pochron NL, Harmsen S, Nagorney DM, Sebo TJ, Therneau TM, Gores GJ, Groen PC, Baron TH, Levy MJ, Halling KC, Roberts LR 2004 A comparison of routine cytology and fluorescence in situ hybridization for the detection of malignant bile duct strictures. Am. J. Gastroenterol. 99: 1675-1681. *

• Kitajima Y, Ohara H, Nakazawa T, Ando T, Hayashi K, Takada H, Tanaka H, Ogawa K, Sano H, Togawa S, Naito I, Hirai M, Ueno K, Ban T, Miyabe K, Yamashita H, Yoshimura N, Akita S, Gotoh K, Joh T 2007 Usefulness of transpapillary bile duct brushing cytology and forceps biopsy for improved diagnosis in patients with biliary strictures. J. Gastroenterol. Hepatol. 22: 1615-1620. *

• Kloek JJ, van Delden OM, Erdogan D, Ten Kate FJ, Rauws EA, Busch OR, Gouma DJ, van Gulik TM 2008 Differentiation of malignant and benign proximal bile duct strictures: the diagnostic dilemma. World J. Gastroenterol. 14: 5032-5038. *

• Kristiansen TZ, Bunkenborg J, Gronborg M, Molina H, Thuluvath PJ, Argani P, Goggins MG, Maitra A, Pandey A 2004 A proteomic analysis of human bile. Mol. Cell. Proteomics 3: 715-728. *

• Kurzawinski T, Deery A, Davidson BR 1993 Diagnostic value of cytology for biliary stricture. Br. J. Surg. 80: 414-421.

• Kurzawinski TR, Deery A, Dooley JS, Dick R, Hobbs KE, Davidson BR 1993 A prospective study of biliary cytology in 100 patients with bile duct strictures. Hepatology 18: 1399-1403.

• Lal A, Okonkwo A, Schindler S, De Frias D, Nayar R 2004 Role of biliary brush cytology in primary sclerosing cholangitis. Acta Cytol. 48: 9-12.

• Langwieler TE, Kim JS, Mann O, Thonke F, Knoefel WT, Rogiers X, Izbicki JR 2004 Management of an unclear bile duct stenosis. Surg. Endosc. 18: 717-718.

• Lara LF, Levy MJ 2004 Idiopathic recurrent acute pancreatitis. MedGenMed. 6: 10.

• Layfield LJ, Cramer H 2005 Primary sclerosing cholangitis as a cause of false positive bile duct brushing cytology: report of two cases. Diagn. Cytopathol. 32: 119-124. *

• Lin LF, Huang PT, Ho KS, Tung JN 2008 Autoimmune chronic pancreatitis. J. Chin. Med. Assoc. 71: 14-22.

• Lindberg B, Arnelo U, Bergquist A, Thorne A, Hjerpe A, Granqvist S, Hansson LO, Tribukait B, Persson B, Broome U 2002 Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis. Endoscopy 34: 909-916.

• Macken E, Drijkoningen M, Van Aken E, Van Steenbergen W 2000 Brush cytology of ductal strictures during ERCP. Acta Gastroenterol. Belg. 63: 254-259.

• Maggs JR, Chapman RW 2007 Sclerosing cholangitis. Curr. Opin. Gastroenterol. 23: 310-316.

• Mansfield JC, Griffin SM, Wadehra V, Matthewson K 1997 A prospective evaluation of cytology from biliary strictures. Gut 40: 671-677. *

• Moff SL, Clark DP, Maitra A, Pandey A, Thuluvath PJ 2006 Utility of bile duct brushings for the early detection of cholangiocarcinoma in patients with primary sclerosing cholangitis. J. Clin. Gastroenterol. 40: 336-341.

• Moreno Luna LE, Kipp B, Halling KC, Sebo TJ, Kremers WK, Roberts LR, Barr Fritcher EG, Levy MJ, Gores GJ 2006 Advanced cytologic techniques for the detection of malignant pancreatobiliary strictures. Gastroenterology 131: 1064-1072. *

• Mosler K, Coraux C, Fragaki K, Zahm JM, Bajolet O, Bessaci-Kabouya K, Puchelle E, Abely M, Mauran P 2008 Feasibility of nasal epithelial brushing for the study of airway epithelial functions in CF infants. J. Cyst. Fibros. 7: 44-53.

• Nehls O, Gregor M, Klump B 2004 Serum and bile markers for cholangiocarcinoma. Semin. Liver Dis. 24: 139-154.

• Ouyang DL, Chen JJ, Getzenberg RH, Schoen RE 2005 Noninvasive testing for colorectal cancer: a review Am. J. Gastroenterol. 100: 1393-1403. *

• Papachristou GI, Demetris AJ, Craig F, Lee KKW, Rabinovitz M 2004 Cholestatic jaundice and bone lesions in an elderly woman. Nat. Clin. Pract. Gastroenterol. Hepatol. 1: 53-57. *

• Patel T, Singh P 2007 Cholangiocarcinoma: emerging approaches to a challenging cancer. Curr. Opin. Gastroenterol. 23: 317-323.

• Ramage JK, Donaghy A, Farrant JM, Iorns R, Williams R 1995 Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology 108: 865-869. *

• Rumalla A, Baron TH, Leontovich O, Burgart LJ, Yacavone RF, Therneau TM, de Groen PC, Sebo TJ 2001 Improved diagnostic yield of endoscopic biliary brush cytology by digital image analysis. Mayo Clin. Proc. 76: 29-33. *

• Sears RJ, Duckworth CW, Decaestecker C, Bourgeois N, Ledent T, Deviere J, Salmon I, Kiss R, Yeaton P 1998 Image cytometry as a discriminatory tool for cytologic specimens obtained by endoscopic retrograde cholangiopancreatography. Cancer 84: 119-126. *

• Siqueira E, Schoen RE, Silverman W, Martin J, Rabinovitz M, Weissfeld JL, Abu-Elmaagd K, Madariaga JR, Slivka A, Martini J 2002 Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis. Gastrointest. Endosc. 56: 40-47. *

• Small AJ, Baron TH 2008 Novel endoscopic approaches for assessing biliary tract diseases. Curr. Opin. Gastroenterol. 24: 357-362.

• Stewart CJ, Mills PR, Carter R, O'Donohue J, Fullarton G, Imrie CW, Murray WR 2001 Brush cytology in the assessment of pancreatico-biliary strictures: a review of 406 cases. J. Clin. Pathol. 54: 449-455. *

• Stiehl A 2002 Primary sclerosing cholangitis: neoplastic potential in bile ducts, colon and the pancreas? J. Hepatol. 36: 433-434. *

• Swain P 2008 The future of wireless capsule endoscopy. World J. Gastroenterol. 14: 4142-4145. *

• Testoni PA, Mariani A, Mangiavillano B, Arcidiacono PG, Di Pietro S, Masci E 2007 Intraductal optical coherence tomography for investigating main pancreatic duct strictures. Am. J. Gastroenterol. 102: 269-274. *

• Tischendorf JJ, Kruger M, Trautwein C, Duckstein N, Schneider A, Manns MP, Meier PN 2006 Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Endoscopy 38: 665-669.

• Tischendorf JJ, Meier PN, Schneider A, Manns MP, Kruger M 2007 Transpapillary intraductal ultrasound in the evaluation of dominant bile duct stenoses in patients with primary sclerosing cholangitis. Scand. J. Gastroenterol. 42: 1011-1017. *

• Torok N, Gores GJ 2001 Cholangiocarcinoma. Semin. Gastrointest. Dis. 12: 125-132.

• van Leeuwen DJ, Reeders JW 1999 Primary sclerosing cholangitis and cholangiocarcinoma as a diagnostic and therapeutic dilemma. Ann. Oncol. 10 Suppl. 4: 89-93.

• Vandervoort J, Soetikno RM, Tham TC, Wong RC, Ferrari AP Jr, Montes H, Roston AD, Slivka A, Lichtenstein DR, Ruymann FW, Van Dam J, Hughes M, Carr-Locke DL 2002 Risk factors for complications after performance of ERCP. Gastrointest. Endosc. 56: 652-656. *

• Wamsteker EJ 2007 Updates in biliary endoscopy 2006. Curr. Opin. Gastroenterol. 23: 324-328.

• Weber A, Schmid RM, Prinz C 2008 Diagnostic approaches for cholangiocarcinoma. World J. Gastroenterol. 14: 4131-4136. *

• Wu Y, Johlin FC, Rayhill SC, Jensen CS, Xie J, Cohen MB, Mitros FA 2008 Long-term, tumor-free survival after radiotherapy combining hepatectomy-Whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma. Liver Transpl. 14: 279-286.

• Xenoulis PG, Palculict B, Allenspach K, Steiner JM, Van House AM, Suchodolski JS 2008 Molecular-phylogenetic characterization of microbial communities imbalances in the small intestine of dogs with inflammatory bowel disease. FEMS Microbiol. Ecol. Jul 21 [Epub ahead of print]. *

• Yokohata K, Shirahane K, Yonemasu H, Nabae T, Inoue K, Ohtsuka T, Yamaguchi K, Chijiiwa K, Tanaka M 2000 Focal ductal branch dilatation on magnetic resonance cholangiopancreatography: a hint for early diagnosis of pancreatic carcinoma. Scand. J. Gastroenterol. 35: 1229-1232. *

• Yoon JH, Gores GJ 2003 Diagnosis, staging, and treatment of cholangiocarcinoma. Curr. Treat. Options Gastroenterol. 6: 105-112.

Number of references = 65

www psc-literature.org